Barclays Lowers Molina Healthcare (NYSE:MOH) Price Target to $347.00

Molina Healthcare (NYSE:MOH - Get Free Report) had its target price dropped by Barclays from $351.00 to $347.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an "equal weight" rating on the stock. Barclays's price target indicates a potential upside of 16.89% from the stock's current price.

A number of other equities analysts have also commented on MOH. Truist Financial increased their price target on shares of Molina Healthcare from $340.00 to $400.00 and gave the stock a "buy" rating in a report on Friday, April 11th. Robert W. Baird reissued a "neutral" rating and issued a $375.00 price target (up previously from $331.00) on shares of Molina Healthcare in a report on Tuesday, April 15th. Morgan Stanley assumed coverage on shares of Molina Healthcare in a report on Monday. They issued an "overweight" rating and a $364.00 price target on the stock. Guggenheim initiated coverage on shares of Molina Healthcare in a report on Wednesday, April 9th. They issued a "neutral" rating on the stock. Finally, Baird R W lowered shares of Molina Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Nine equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, Molina Healthcare currently has an average rating of "Hold" and an average target price of $364.21.

Molina Healthcare Price Performance

Shares of Molina Healthcare stock traded down $0.02 during trading on Monday, hitting $296.87. The stock had a trading volume of 438,633 shares, compared to its average volume of 684,610. The firm has a market cap of $16.09 billion, a price-to-earnings ratio of 14.53, a P/E/G ratio of 1.06 and a beta of 0.56. Molina Healthcare has a 12 month low of $262.32 and a 12 month high of $365.23. The business's 50-day moving average is $319.91 and its 200 day moving average is $307.40. The company has a current ratio of 1.62, a quick ratio of 1.62 and a debt-to-equity ratio of 0.69.

Molina Healthcare (NYSE:MOH - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping analysts' consensus estimates of $5.96 by $0.12. The firm had revenue of $11.15 billion for the quarter, compared to analyst estimates of $10.86 billion. Molina Healthcare had a net margin of 2.90% and a return on equity of 28.13%. The business's revenue for the quarter was up 12.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $5.73 EPS. As a group, sell-side analysts anticipate that Molina Healthcare will post 24.4 earnings per share for the current year.

Insiders Place Their Bets

In other Molina Healthcare news, CEO Joseph M. Zubretsky sold 87,500 shares of the firm's stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer now owns 257,715 shares of the company's stock, valued at $82,484,262.90. This trade represents a 25.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director now directly owns 11,244 shares in the company, valued at approximately $3,603,702. This trade represents a 5.62% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.10% of the company's stock.

Institutional Investors Weigh In On Molina Healthcare

A number of large investors have recently added to or reduced their stakes in the company. Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Molina Healthcare by 29.9% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 6,545 shares of the company's stock worth $1,909,000 after purchasing an additional 1,506 shares during the period. Choreo LLC raised its stake in Molina Healthcare by 7.7% in the fourth quarter. Choreo LLC now owns 1,115 shares of the company's stock worth $323,000 after buying an additional 80 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in Molina Healthcare by 2.2% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 149,573 shares of the company's stock worth $43,533,000 after buying an additional 3,238 shares in the last quarter. Empirical Finance LLC raised its stake in Molina Healthcare by 53.8% in the fourth quarter. Empirical Finance LLC now owns 4,632 shares of the company's stock worth $1,348,000 after buying an additional 1,621 shares in the last quarter. Finally, Entropy Technologies LP raised its stake in Molina Healthcare by 58.1% in the fourth quarter. Entropy Technologies LP now owns 4,594 shares of the company's stock worth $1,337,000 after buying an additional 1,688 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.